Search

everythinglearnresearchcommunity

for

Search:↓

Taking zinc supplements can help improve or cure hair loss caused by zinc deficiency.

Iron deficiency might contribute to hair loss in women.

Hair loss doesn't affect COVID-19 severity.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

The Drug Ontology was updated to better classify drugs for hypertension, malaria, and opioid abuse, and to allow for more accurate research queries.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Minoxidil in breast milk may harm nursing infants.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

Melatonin receptors in hair follicles help regulate hair growth and could treat hair loss.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

Older adults in Vietnam often experience hair loss after COVID-19, especially women, singles, and those hospitalized.

Social media data can help track and predict COVID-19 symptoms and trends.

Hairless protein is key for hair growth, cell differences cause gene expression variation, and the N-end rule pathway senses nitric oxide for protein breakdown.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Finasteride worsens heart damage but reduces cell toxicity caused by nandrolone decanoate.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

Caffeine may help reduce stress-induced hair loss.

Testosterone may influence COVID-19 severity and outcomes.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

COVID-19 infection can significantly cause temporary hair loss.

Chitosan hydrogels are promising for repairing blood vessels but need improvements in strength and compatibility.

Ectoin helps prevent cortisone-induced skin problems and supports skin health.